Impact of Adipose Tissue Repartition on the Time Course of Vascular Dysfunction - the NUMEVOX Cohort

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00997165

Acronym

NUMEVOX

Enrollment

500

Registered

2009-10-19

Start date

2008-03-31

Completion date

2017-03-31

Last updated

2009-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atherosclerosis, Metabolic Diseases, Sleep Apnea

Keywords

fatty liver, adipose tissue

Brief summary

The NUMEVOX cohort is intended to follow-up the macro and microvascular dysfunction in relation to adipose tissue repartition in patients with metabolic syndrome associated to liver steatosis, sleep apnea. Duration of the follow-up is 3 years for each patient entering the cohort.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* informed consent * age \> 18 years old * suspected of metabolic syndrome * affiliated to french social health care

Exclusion criteria

* age \< 18 years old * pregnancy * no informed consent * not eligible for the study (no MS, cancer)

Countries

France

Contacts

Primary ContactPIERRE HENRI DUCLUZEAU, MD PhD

phducluzeau@chu-angers.fr33(0)663384160

Backup ContactGEORGES LEFTHERIOTIS, MD-PHD

geleftheriotis@chu-angers.fr33(2)41-35-44-56

Outcome results